R P A'Hern Selected Research

R P A'Hern Research Topics

3	Melanoma (Melanoma, Malignant) 08/2004 - 07/2000
2	Breast Neoplasms (Breast Cancer) 09/2005 - 05/2004
2	Neoplasms (Cancer) 07/2000 - 03/2000
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2006
1	Carcinoma (Carcinomatosis) 09/2000
1	Wounds and Injuries (Trauma) 08/2000
1	Neoplasm Metastasis (Metastasis) 07/2000
1	Neutropenia 03/2000
1	Ovarian Neoplasms (Ovarian Cancer) 03/2000
1	Cardiotoxicity 03/2000
1	Ovarian Epithelial Carcinoma 03/2000
1	Lethargy 03/2000
1	Thrombocytopenia (Thrombopenia) 03/2000

3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2005 - 03/2000
3	Epirubicin (Ellence)FDA LinkGeneric 09/2005 - 03/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2005 - 03/2000
3	Cisplatin (Platino)FDA LinkGeneric 05/2004 - 03/2000
1	thiamine triphosphorate (TTP)IBA 03/2006
1	Gefitinib (Iressa)FDA Link 03/2006
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2005
1	Fluorouracil (Carac)FDA LinkGeneric 05/2004
1	Tamoxifen FDA LinkGeneric 09/2000
1	Interferon alpha-2 (Roferon-A)FDA Link 09/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2000
1	Dacarbazine (DIC)FDA LinkGeneric 09/2000
1	Biological ProductsIBA 07/2000
1	Carboplatin (JM8)FDA LinkGeneric 03/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2000
1	PlatinumIBA 03/2000
1	AnthracyclinesIBA 03/2000

2	Radiotherapy 08/2004 - 09/2000
2	Drug Therapy (Chemotherapy) 05/2004 - 03/2000
1	Palliative Care (Palliative Therapy) 03/2006
1	Therapeutics 09/2005
1	Immunotherapy 09/2000
1	Adjuvant Radiotherapy 09/2000
1	Hysterectomy 08/2000
1	Chemoprevention 07/2000